About
Diagnostic and therapeutic products for oncology
Areas of Focus
Categories
DiagnosticsBiologics & Biopharmaceutical
Clinical Trials (10)
View allTotal Trials
10
As Lead Sponsor
9
As Collaborator
1
Total Enrollment
1,490
By Phase
PHASE1/PHASE2: 2PHASE3: 3PHASE1: 3PHASE2: 2
By Status
COMPLETED: 5TERMINATED: 3RECRUITING: 1WITHDRAWN: 1
Clinical Trials Pipeline10 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT04879043Lead Sponsor
Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma
PHASE1/PHASE2Recruiting
78 participants
Started: Feb 7, 2022 · Completed: May 31, 2026
NCT01762592Lead Sponsor
REDECT 2: REnal Masses: Pivotal Trial to DEteCT Clear Cell Renal Cell Carcinoma With PET/CT
PHASE3Withdrawn
Started: Dec 31, 2017 · Completed: Dec 31, 2019
NCT01859351Lead Sponsor
Phase I Study of WX-037 Alone and in Combination With WX-554 in Solid Tumours
PHASE1Terminated
13 participants
Started: Jul 31, 2013 · Completed: Apr 30, 2014
NCT01581060Lead Sponsor
Phase I/II Dose-escalation Study to Investigate Safety and Pharmacokinetics/ Pharmacodynamics of WX-554 in Patients With Solid Tumours
PHASE1/PHASE2Terminated
41 participants
Started: Mar 31, 2012 · Completed: Apr 30, 2014
NCT00615940Lead Sponsor
Combination of Oral WX-671 Plus Capecitabine vs. Capecitabine Monotherapy in First-line Her2-negative Metastatic Breast Cancer
PHASE2Completed
132 participants
Started: Jul 31, 2008 · Completed: Apr 30, 2012
Locations (1)
Headquarters
Ladenburg, Germany
Map
Loading map...